Document is current
Any future updates will be listed below
-
Authors
Rodrigo-Muñoz, José M.
Sastre, Beatriz
Sánchez-García, Laura
García-García, María Luz
Gonzalez-Carrasco, Ersilia
Fabra, Celia
Gil-Martínez, Marta
Lorente-Sorolla, Clara
García-Latorre, Raquel
Alcolea, Sonia
Casas, Inmaculada
Calvo, Cristina https://orcid.org/0000-0002-6503-3423
del Pozo, Victoria https://orcid.org/0000-0001-6228-1969
-
Funding
Funding for this research was provided by:
CIBER de Enfermedades Respiratorias
Instituto de Salud Carlos III (FI19/00067, PI18/00167, PI18CIII/00009)
- License Information
-
More Information
Article History
Received: 30 March 2022
Accepted: 6 December 2022
First Online: 8 December 2022
Competing interests
: Victoria del Pozo has been a consultant/speaker for AstraZeneca and GSK. The rest of authors declare that they have no potential conflicts of interest.
